For its first phocean edition, BioFIT confirms its status as the leading European partnering event for early-stage deals and investment rounds in the Life Sciences field. Over 1,150 attendees from over 35 countries attended BioFIT’s 8th edition: 120+ exhibitors, 70 speakers, 16 conferences and 4 projects elected as the most innovative in their categories were gathered in Marseille at Parc Chanot on December 10th and 11th.
Review BioFIT 2019: A great first edition in Marseille
Sponsored PublicationsFor its first phocean edition, BioFIT confirms its status as the leading European partnering event for early-stage deals and investment rounds in the Life Sciences field. Over 1,150 attendees from over 35 countries attended BioFIT’s 8th edition: 120+ exhibitors, 70 speakers, 16 conferences and 4 projects elected as the most innovative in their categories were gathered in Marseille at Parc Chanot on December 10th and 11th.
Mereo BioPharma raise money to back Phase III trials
Latest NewsMereo BioPharma has entered into a $5m convertible equity financing with Novartis and a $28m securities purchase agreement with Aspire Capital Fund.
Stilla raises €20m in series B financing round
Latest NewsFrench Stilla Technologies SA raised €20m in a Series B funding to boost digital PCR-based genetic testing.
BIH scientists optimise CRISPR gene scissors
Latest NewsTargeted genome editing using the CRISPR-Cas9 system is easy to use but far from being perfect. Computer calculated modification of CRISPR activity can reduce "off-target effects".
Azafaros BV raises €25m in Series A round
Latest NewsDutch biotech Azafaros B.V. has closed a €25m Series A financing round.
Researchers identify roots of childhood asthma
Latest NewsInfants who show defective immune responses to microbial components are more likely to acquire asthma later in childhood, according to a study of 541 children.
MaaT Pharma raise €18m to advance clinical pipeline
Latest NewsMaaT Pharma SA has announced €18m Series B financing to boost its microbiome biotherapeutics pipeline.
Centrient Pharmaceuticals: New CEO
AppointmentsEx-Sandoz Head of Global Franchises Rex Clements is taking over as CEO of Centrient Pharmaceuticals. Erstwhile Centrient CEO Karl Rotthier has decided to step down, the company said.
Valneva raises US$85m
Latest NewsFrench vaccine developer Valneva SA will raise $85m in a financing arrangement with Deerfield and OrbiMed and go Nasdaq to co-fund its Lyme disease programme.
EMA greenlights 15 new meds
Latest NewsThe EMA’s human medicines committee (CHMP) recommended fifteen medicines for approval at its January 2020 meeting.